Experienced entrepreneur, scientist, and executive with over 20 years of product development, business development, and team management in defense and biotech. Previously, the Co-Founder, CEO & CSO of C2i Genomics, taking the company from a research concept to a global commercial leader. 

​

Inventor of the “Eigengene.” USTAR associate professor at the Scientific Computing and Imaging Institute and the Huntsman Cancer Institute at the University of Utah, and a member of the scientific advisory board of the NCI-DOE Cancer Moonshot collaboration on predictive oncology.

​

Technology leader with 11 years of experience from Facebook/Meta in leading engineering roles. Built and managed high-performing engineering organizations of over 300 people across multiple locations. Utilized AI/ML, scalable systems design, and data privacy concepts for products at large scale with billions of users. 

Biotech business leader with over 30 years of experience in executive roles. Previously led multiple commercial and business development teams at Foundation Medicine, Tempus AI, C2i Genomics, and Culmination Bio. Serves on the board of directors at multiple startup companies.

​​​

MIT and Stanford engineer. Founder of Jazzle, Inc. Inventor of the non-epitaxial light-emitting diode (US 5925897 A);

​

​

​

​

​

20 years of accounting and finance experience and 10 years of startup experience in the NYC area that includes private and public companies based in the US and Israel.  Most recently helped to complete the due diligence, sale and transition of C2i Genomics to Veracyte.

​

​

Dr. Sidransky is a renowned oncologist, research scientist, and serial entrepreneur, profiled by TIME magazine in 2001 as one of America's best in science and medicine. A leading expert in oncology and precision medicine, Dr. Sidransky is widely respected in the biopharmaceutical industry.

​